Atlas Trials

Selective Lymph Node Dissection Using Fluorescent Dye in Node-positive Breast Cancer

Clinical trial NCT02781259 · UNKNOWN

Trial details

NCT number
NCT02781259
Sponsor
Samsung Medical Center
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Breast Neoplasms
Start date
2016-05-01
Primary completion
2017-02-01
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.